THOR MEDICAL ASA (TRMED.OL) Stock Income Statement
OSL:TRMED • NO0010597883
Current stock price
4.425 NOK
+0.17 (+4.12%)
Last:
| 2025 (2025-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 439.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 73.52M | 7.20M | 316.45M | 442.43M | 434.16M | |||
| Research and Development | 2.06M | 945.00K | 202.54M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 50.30M | 4.91M | 108.21M | 91.64M | 78.30M | |||
| Operating Income | -73.08M | -7.20M | -316.45M | -442.43M | -434.16M | |||
| Interest Income/Expense | 7.38M | 1.77M | 7.08M | 2.44M | 18.39M | |||
| Other Income/Expense | 1.00K | -169.00K | -90.00K | -140.00K | -390.00K | |||
| Non Recurring Items | 3.42M | 41.00K | -910.00K | N/A | N/A | |||
| Income Before Taxes | -62.27M | -5.56M | -310.37M | -440.14M | -416.16M | |||
| Income Tax | -4.26M | 0.00 | 870.00K | 1.17M | 910.00K | |||
| Net Income | -58.01M | -26.56M | -311.24M | -441.30M | -417.08M | |||
| EBITDA | -52.15M | -6.48M | -305.25M | -431.06M | -419.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.17 | -0.15 | -2.70 | -4.65 | -5.95 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -5.91 | |||
| Statistics | ||||||||
| Profit Margin | -13214.58% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -16646.01% | N/A | N/A | N/A | N/A | |||
All data in NOK